Clinical trial risk estimation
The platform estimates clinical trial risk and interprets factors contributing to that risk.
Source: LinkedIn company description · Retrieved October 13, 2026
Intelligencia AI uses artificial intelligence to assess drug development risk.
Its platform estimates clinical trial risk and interprets factors that contribute to that risk. Its interdisciplinary team combines and interprets disparate data across the life sciences industry.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company works with large global pharmaceutical companies and mid-size and smaller biotechnology companies.
The platform estimates clinical trial risk and interprets factors contributing to that risk.
Source: LinkedIn company description · Retrieved October 13, 2026
The platform offers machine-learning predictions to enable critical decision-making.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 4, 2026, September 6, 2026, September 7, 2026, September 10, 2026, September 13, 2026, September 15, 2026, September 18, 2026, September 19, 2026, September 20, 2026, September 26, 2026, September 27, 2026, September 28, 2026, September 30, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.